ArticlePharmaceutics2021

Antitumor Activity of Nanoparticles Loaded with PHT-427, a Novel AKT/PDK1 Inhibitor, for the Treatment of Head and Neck Squamous Cell Carcinoma.

Joaquín Yanes-Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.